Bromide, Serum or Plasma
Ordering Recommendation

Monitor drug therapy or use when  bromide toxicity is suspected  (eg, hyperchloremia with negative anion gap and altered mental status).

Quantitative Spectrophotometry
Mon, Thu
1-5 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Plain Red, Lavender (K2EDTA), Lavender (K3EDTA), or Pink (K2EDTA). 
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL) 
Storage/Transport Temperature
Unacceptable Conditions
Whole blood. Gel Separator Tubes, Light Blue (Sodium Citrate), or Yellow (SPS or ACD Solution). 
Please indicate in the supplied fields:
1.  Dose - List drug amount and include the units of measure
2.  Route - List the route of administration (IV, oral, etc.)
3.  Dose Frequency - Indicate how often the dose is administered (per day, per week, as needed, etc.)
4.  Type of Draw - Indicate the type of blood draw (Peak, Trough, Random, etc.) 
Ambient: 1 week; Refrigerated: 1 weeks; Frozen: Indefinitely 
Reference Interval
Therapeutic Range:
Sedation: 10-50 mg/dL (values greater than 50 mg/dL may be associated with mild toxicity)
Epilepsy seizure control:  75-150 mg/dL (many patients will exhibit toxic symptoms within this range)
Greater than 150 mg/dL: May be associated with debilitating toxicity
Greater than 300 mg/dL: May be fatal
Interpretive Data
The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration.

Component Test Code*Component Chart NameLOINC
2011437Bromide Dose Frequency
2011438Bromide Route
2011439Bromide Type of Draw49049-0
2011440Bromide, Ser/Pla1984-4
2011441Bromide Dose65818-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • Triple Bromide